Back
Citius Pharmaceuticals, Inc. Stock Price Chart
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
42
CTXR
Citius Pharmaceuticals, Inc.
Last Price:
$1.23
Seasonality Move:
23.69%
7 Day Trial
ALL ACCESS PASS
$
7
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is relatively stagnant and CTXR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Citius Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.28 | Sell |
| 20-day SMA: | 1.17 | Buy |
| 50-day SMA: | 1.33 | Sell |
| 200-day SMA: | 1.26 | Sell |
| 8-day EMA: | 1.24 | Buy |
| 20-day EMA: | 1.24 | Buy |
| 50-day EMA: | 1.28 | Sell |
| 200-day EMA: | 2.44 | Sell |
Citius Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 49.76 | Sell |
| Chaikin Money Flow: | 345722 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.05 - 1.41) | Buy |
| Bollinger Bands (100): | (1.14 - 1.5) | Sell |
Citius Pharmaceuticals, Inc. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Citius Pharmaceuticals, Inc. Stock
Is Citius Pharmaceuticals, Inc. Stock a Buy?
-
Citius Pharmaceuticals, Inc. share price is 1.25 while CTXR 8-day simple moving average is 1.28, which is a Sell signal.
-
The stock price of CTXR is 1.25 while Citius Pharmaceuticals, Inc. 20-day SMA is 1.17, which makes it a Buy.
-
Citius Pharmaceuticals, Inc. 50-day simple moving average is 1.33 while CTXR share price is 1.25, making it a Sell technically.
-
CTXR stock price is 1.25 and Citius Pharmaceuticals, Inc. 200-day simple moving average is 1.26, creating a Sell signal.
CTXR Technical Analysis vs Fundamental Analysis
Sell
42
Citius Pharmaceuticals, Inc. (CTXR)
is a Sell
Is Citius Pharmaceuticals, Inc. a Buy or a Sell?
-
Citius Pharmaceuticals, Inc. stock is rated a SellThe current Citius Pharmaceuticals, Inc. [CTXR] share price is $1.25. The Score for CTXR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Citius Pharmaceuticals, Inc. Stock Info
Market Cap:
23.1M
Price in USD:
1.25
Share Volume:
469.3K
Citius Pharmaceuticals, Inc. 52-Week Range
52-Week High:
5.95
52-Week Low:
0.65
Sell
42
Citius Pharmaceuticals, Inc. (CTXR)
is a Sell
Citius Pharmaceuticals, Inc. Share Price Forecast
-
What is the Citius Pharmaceuticals, Inc. stock price today?The Citius Pharmaceuticals, Inc. stock price is 1.25 USD today.
-
Will CTXR stock go up or go down?Citius Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Citius Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Pharmaceuticals, Inc. is overvalued.
Is Citius Pharmaceuticals, Inc. Stock a Buy?
-
Citius Pharmaceuticals, Inc. share price is 1.25 while CTXR 8-day exponential moving average is 1.24, which is a Buy signal.
-
The stock price of CTXR is 1.25 while Citius Pharmaceuticals, Inc. 20-day EMA is 1.24, which makes it a Buy.
-
Citius Pharmaceuticals, Inc. 50-day exponential moving average is 1.28 while CTXR share price is 1.25, making it a Sell technically.
-
CTXR stock price is 1.25 and Citius Pharmaceuticals, Inc. 200-day simple moving average is 2.44, creating a Sell signal.
Fundamental Analysis of Citius Pharmaceuticals, Inc.
Is Citius Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.55 per share, and an increase next year of $3.98 per share.
Technical Analysis of Citius Pharmaceuticals, Inc.
Should I short Citius Pharmaceuticals, Inc. stock?
-
CTXR Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Citius Pharmaceuticals, Inc. is a Sell
-
Citius Pharmaceuticals, Inc. Relative Strength Index (RSI) is 49.76, which suggest Citius Pharmaceuticals, Inc. is oversold
-
The Bollinger Bands (25) for Citius Pharmaceuticals, Inc. is (1.05 - 1.41), which suggest Citius Pharmaceuticals, Inc. is a Sell
-
The Bollinger Bands (100) for Citius Pharmaceuticals, Inc. is (1.14 - 1.5), which suggest Citius Pharmaceuticals, Inc. is a Sell
* Citius Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.